All News

Study finds higher Ischemic events and mortality in transcatheter valve replacement patients taking non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists.

Low-risk atrial fibrillation patients who take oral anticoagulants have a lower risk of dementia than those who do not, a study says.

Changes to vaccine recommendations for older adults may mean they have to pay for pneumococcal vaccine themselves.

Virus-like particle research could lead to a vaccine against opioid addiction.

Indications include breast cancer, metastatic gastric cancer, and metastatic gastroesophageal junction adenocarcinoma.

Both responder and remitter patients experienced a statistically significant longer time to relapse with esketamine compared to the placebo

Billing solutions and entrepreneurs needed. 

DIR abuse might require Presidential and Congressional intervention.

Be an expert at evaluating clinical studies with some ­simple tools.

Comply with state and federal regulations on dispensing and handling controls to avoid possible disciplinary or DEA actions and penalties.

Organization calls for state-level legislative and regulatory revisions.

Figuring out the equations for quality technicians.

Results from a new Massachusetts Health Policy Commission report.

Two studies outline the risks of shingles for patients with IBD.

A study finds herpes viruses can reemerge under the stresses of spaceflight.

Pharmacists can earn up to 27 hours of CE. 

CVS will expand its health offerings, including nutrition and weight loss.

Results of a recent survey suggest employee-based drug abuse is a concern for many healthcare providers, though they don’t believe it can happen in their facilities.

Zerbaxa is a cephalosporin antibacterial and beta-lactamase inhibitor combination drug originally approved for abdominal and urinary tract infections.

Patients on Emgality experienced an average of 8.7 fewer weekly episodic cluster headaches.

Training programs reflect the changing practice of pharmacies.

Improve your counseling skills to make the most of medication therapy management in your community pharmacy.

The agreement will bring real-world data to cancer treatment development.

After several manufacturing and sterility issues, a permanent injunction has been issued against a Pharm D Solutions, LLC.

The action by the U.S. Attorney's Office is the latest in legal and policy maneuvers aimed at ending the opioid epidemic.

Earn up to 19.25 hours of CE.

This thalidomide analogue is also indicated for multiple myeloma and myelodysplastic syndromes.

New indication adds to the oral antipsychotic’s portfolio of conditions.